期刊档案

Acta Pharmaceutica Sinica B

— · ISSN 2211-3835 · Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics

数据可追溯 · letpub-v6 · 更新于 2026-08-26
影响指标14.49
h-index28
平均审稿速度期刊官网数据:平均Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days;网友分享经验:19 Weeks
平均录用比例网友分享经验:来源Elsevier官网:9%

期刊简介

研究范围与定位

The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical AssociationPeer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical AssociationActa Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.

结构化分区

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 2 个学科记录

Top:是综述:N/A
类别学科分区
大类医学1区
小类药学PHARMACOLOGY & PHARMACY1区

期刊分区表( 2025年3月升级版)

2025-03 · 2 个学科记录

Top:是综述:否
类别学科分区
大类医学1区
小类药学PHARMACOLOGY & PHARMACY1区

期刊分区表( 2023年12月旧的升级版)

2023-12 · 2 个学科记录

Top:是综述:否
类别学科分区
大类医学1区
小类药学PHARMACOLOGY & PHARMACY1区

期刊档案

出版与身份

期刊ISSN
2211-3835
E-ISSN
2211-3843
是否OA开放访问
Yes
通讯方式
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES, C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, PEOPLES R CHINA, 10005
出版商
Elsevier BV
出版国家或地区
CHINA MAINLAND
出版语言
English
出版周期
Monthly
出版年份
2011

期刊档案

研究范围

期刊简介
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical AssociationPeer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical AssociationActa Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.
涉及的研究方向
Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics

期刊档案

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子
截止2026年5月06日:14.49
2025-2026自引率
4.1%点击查看自引率趋势图
五年IF(数据来源于网友提供)
16.896数据由网友[byte8848]收集提供
h-index
28
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名24.403.4392.516学科分区排名百分位大类:Pharmacology, Toxicology and Pharmaceutics小类:General Pharmacology, Toxicology and PharmaceuticsQ11 / 79 99%
年文章数
345点击查看年文章数趋势图
Gold OA文章占比
99.37%
研究类文章占比:文章 ÷(文章 + 综述)
79.71%

期刊档案

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
SCI期刊收录coverage
Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接
访问官方页面 ↗

期刊档案

投稿与评审

期刊官方网站
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b 投稿规范预检(避免 Desk Rejection) 开始检查>>
期刊投稿网址
https://www.editorialmanager.com/apsb/default.aspx AI辅助快速完成投稿信初稿 一键撰写投稿信>>
作者指南网址
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/publish/guide-for-authors 提前检查论文语言风险 AI 写作痕迹检测>>
平均审稿速度
期刊官网数据:平均Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days;网友分享经验:19 Weeks
平均录用比例
网友分享经验:来源Elsevier官网:9%

来源与统计口径

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。